SCHEMBL19486134

SCHEMBL19486134

CCOCCNC(=O)O[C@H]1CC[C@@]2(C)C(=CCC3C4CCC(C(C)CCCC(C)C)[C@@]4(C)CCC32)C1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ POLA1 P09884 1/20 0.67
▸ CYP46A1 Q9Y6A2 2/20 0.65
▸ OSBP P22059 3/20 0.61
▸ USP2 O75604 2/20 0.61
▸ RORC P51449 2/20 0.61
▸ LMNA P02545 1/20 0.61
▸ ABCB1 P08183 1/20 0.61
▸ OSBP2 Q969R2 1/20 0.61
▸ NPC1L1 Q9UHC9 3/20 0.57
▸ NPC1 O15118 1/20 0.56
▸ GBA1 P04062 2/20 0.55
▸ UGCG Q16739 2/20 0.55
▸ GBA2 Q9HCG7 2/20 0.55
▸ NR1H3 Q13133 3/20 0.55
▸ PLA2G2A P14555 1/20 0.55
▸ CYP1A2 P05177 1/20 0.53
▸ GRIN1 Q05586 1/20 0.53
▸ GRIN2A Q12879 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11948053 0.98 POLA1 (0.65) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL15702066 0.98 POLA1 (0.65) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL14963546 0.96 POLA1 (0.65) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL20851995 0.96 POLA1 (0.65) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL14031535 0.96 POLA1 (0.65) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL26032426 0.95 POLA1 (0.66) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL26032453 0.94 POLA1 (0.65) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL14258542 0.94 POLA1 (0.61) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL14258526 0.94 POLA1 (0.62) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL14258523 0.94 POLA1 (0.62) POLA1CYP46A1OSBPUSP2RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10000754-B2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) SIRNA THERAPEUTICS, INC. (US) 2018-06-19 — — US disclosed
US-20170298355-A1 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) BANK OF AMERICA, N.A. 2017-10-19 — — US disclosed
Send feedback